Birk Venture joined the Oslo Cancer Cluster last year. The young
venture company’s specialization is within the Biotech and Life Science
sector in Norway and Scandinavia. Hans Ivar Robinson, Managing
Director and Chairman, states that in the beginning they were aiming
for broad investments. However, Birk`s portfolio shows that oncology
by far is the most preferred field.
